| Thomas E Stevens Jr, MD | |
|
2809 Denny Ave, Pascagoula, MS 39581-5301 | |
| (228) 809-5510 | |
| (228) 809-5519 |
| Full Name | Thomas E Stevens Jr |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 36 Years |
| Location | 2809 Denny Ave, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124067368 | NPI | - | NPPES |
| 51028907 | Other | AL | BCBS |
| 51077048 | Other | AL | BCBS |
| 51593818 | Other | AL | BCBS - 954 NAVCO RD |
| 04-11062 | Other | AL | UNITED HEALTHCARE |
| 000028907 | Medicaid | AL | |
| 110144785 | Other | AL | RAILROAD MEDICARE PTAN |
| 00121547 | Medicaid | MS | |
| 263706500 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 20203 (Alabama) | Secondary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 12159 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deaconess Homecare- Region 1 | Laurel, MS | Home health agency |
| Encompass Health Home Health Of Gulf Coast | Gulfport, MS | Home health agency |
| Saads Home Nursing Of Ms | Diberville, MS | Home health agency |
| Kare In Home Health Services | Gulfport, MS | Home health agency |
| Singing River Health System | Pascagoula, MS | Hospital |
| Singing River Skilled Nursing Facility | Pascagoula, MS | Nursing home |
| Singing River Health And Rehabilitation Center | Moss point, MS | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Exceed Physical Therapy Llc | 8123378338 | 82 |
| Singing River Health System | 3870405194 | 156 |
News Archive
A team of scientists from the University of California, Los Angeles, USA, recently conducted a survey investigating the association between availability of testing facilities and COVID-19-related behavioral aspects. Their findings reveal that testing unavailability independently influences certain COVID-19-related behaviors that may increase the risk of SARS-CoV-2 transmission.
Chronic and non-healing wounds-one of the most devastating complications of diabetes and the leading cause of limb amputation-affects millions of Americans each year. Due to the complex nature of these wounds, proper clinical treatment has been limited.
New IMBRUVICA (ibrutinib) Phase II data announced by Pharmacyclics, Inc. today demonstrates its potential utility as a combination therapy when used with rituximab. Data suggest that the overall efficacy and safety profile of IMBRUVICA is well tolerated when combined with rituximab in patients with relapsed or refractory mantle cell lymphoma (MCL).
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
The COVID-19 pandemic is threatening three decades of improvement in health and social services for women, newborns, children and adolescents.
› Verified 4 days ago
| Entity Name | Singing River Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
A team of scientists from the University of California, Los Angeles, USA, recently conducted a survey investigating the association between availability of testing facilities and COVID-19-related behavioral aspects. Their findings reveal that testing unavailability independently influences certain COVID-19-related behaviors that may increase the risk of SARS-CoV-2 transmission.
Chronic and non-healing wounds-one of the most devastating complications of diabetes and the leading cause of limb amputation-affects millions of Americans each year. Due to the complex nature of these wounds, proper clinical treatment has been limited.
New IMBRUVICA (ibrutinib) Phase II data announced by Pharmacyclics, Inc. today demonstrates its potential utility as a combination therapy when used with rituximab. Data suggest that the overall efficacy and safety profile of IMBRUVICA is well tolerated when combined with rituximab in patients with relapsed or refractory mantle cell lymphoma (MCL).
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
The COVID-19 pandemic is threatening three decades of improvement in health and social services for women, newborns, children and adolescents.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas E Stevens Jr, MD 2809 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 809-5510 | Thomas E Stevens Jr, MD 2809 Denny Ave, Pascagoula, MS 39581-5301 Ph: (228) 809-5510 |
News Archive
A team of scientists from the University of California, Los Angeles, USA, recently conducted a survey investigating the association between availability of testing facilities and COVID-19-related behavioral aspects. Their findings reveal that testing unavailability independently influences certain COVID-19-related behaviors that may increase the risk of SARS-CoV-2 transmission.
Chronic and non-healing wounds-one of the most devastating complications of diabetes and the leading cause of limb amputation-affects millions of Americans each year. Due to the complex nature of these wounds, proper clinical treatment has been limited.
New IMBRUVICA (ibrutinib) Phase II data announced by Pharmacyclics, Inc. today demonstrates its potential utility as a combination therapy when used with rituximab. Data suggest that the overall efficacy and safety profile of IMBRUVICA is well tolerated when combined with rituximab in patients with relapsed or refractory mantle cell lymphoma (MCL).
Researchers at IRB Barcelona describe for the first time how to prepare a specific type of aggregate of the amyloid-beta protein with the ability to perforate the cell membrane.
The COVID-19 pandemic is threatening three decades of improvement in health and social services for women, newborns, children and adolescents.
› Verified 4 days ago
Dr. Randy Roth, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5510 Fax: 228-809-5519 | |
James Lee Harwell, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5510 Fax: 228-809-5519 | |
Ediz Tasan, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Hospital St Ste 102, Pascagoula, MS 39581 Phone: 228-762-1002 | |
Dr. Edgar Hull, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Olusola Isikalu, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2712 Criswell Ave, Pascagoula, MS 39567 Phone: 228-762-0713 Fax: 228-762-0712 | |
Hugo A Quintana, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 4211 Hospital St Ste 202, Pascagoula, MS 39581 Phone: 228-372-8270 Fax: 228-372-8270 |